Panagora Asset Management Inc Blueprint Medicines Corp Transaction History
Panagora Asset Management Inc
- $20.5 Billion
- Q3 2024
A detailed history of Panagora Asset Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Panagora Asset Management Inc holds 96,806 shares of BPMC stock, worth $8.74 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
96,806
Previous 147,564
34.4%
Holding current value
$8.74 Million
Previous $15.9 Million
43.72%
% of portfolio
0.04%
Previous 0.08%
Shares
19 transactions
Others Institutions Holding BPMC
# of Institutions
351Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$604 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$600 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$487 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$358 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$250 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.39B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...